Introduction
Mutations in the PTPN6 gene that encodes for the protein tyrosine phosphatase Src homology region 2 (SH2) domain-containing phosphatase 1 (SHP-1) have been linked with autoinflammatory and autoimmune diseases in humans (1) (2) (3) . Hypomorphic Ptpn6 mutant mice with a homozygous Tyr208Asn amino acid mutation (exhibiting spontaneous inflammation, or spin, and referred to as Ptpn6 spin mice here) develop persistent footpad swelling and suppurative inflammation that are very similar to neutrophilic dermatosis in humans (4, 5) . Neutrophilic dermatosis encompasses disorders that are characterized by neutrophilic infiltration not associated with infection (6) , such as Sweet's Syndrome and pyoderma gangrenosum. While the essential role of IL-1 in promoting these autoinflammatory diseases is well established, the specific roles for IL-1α and IL-1β have only recently been recognized (5, 7) . Using Ptpn6 spin mice as a model of inflammatory disease, we previously showed that IL-1α, but not IL-1β, is a central cytokine that promotes neutrophilic footpad inflammation (5) . Mechanistically, receptor interacting protein kinase 1 (RIPK1) has been shown to regulate IL-1α expression independently of RIPK3, suggesting a role for a RIPK1 and IL-1α signaling axis in driving footpad inflammation (5) . Several studies including ours have demonstrated that hematopoietic or neutrophil-specific deletion of Ptpn6 is sufficient to promote neutrophilic footpad inflammation (5, 8) .
Genetic approaches enabled us to delineate the molecular mechanisms and signaling pathways that are regulated by SHP-1 to modulate inflammation. Our recent studies demonstrated a central role for IL-1α, IL-1R, MyD88, tumor growth factor β-activated kinase 1 (TAK1), spleen tyrosine kinase (SYK), and RIPK1 in promoting inflammatory disease in Ptpn6 spin mice, independent of interferon-α/β receptor (IFNAR), stimulator of interferon genes (STING), integrin beta 3 (ITGB3), and nucleotidebinding oligomerization domain 2-RIPK2 (NOD2-RIPK2) signaling (5, 9, 10) . Excessive inflammatory responses and persistent tissue damage in Ptpn6 spin mice are driven by RIPK1-mediated MAPKs and NF-κB signaling in hematopoietic cells (5, 9) . Given that TAK1 is a central regulator of NF-κB, ERK, and p38 downstream of TLR activation (11-13), we hypothesized that other MAPKs might also play a pivotal role in mediating inflammatory skin disease in Ptpn6 spin mice. MAPKs are Ser/Thr kinases involved in relaying extracellular signals to regulate survival, apoptosis, metabolism, inflammation, and many other cellular processes (14) . Conventional MAPKs include the p38 isoforms JNK 1/2/3 and ERK1/2. These MAPKs are regulated by a series of upstream kinases including TAK1 and apoptosis-signal regulating kinase (ASK) (15) . The ASK family of MAP3Ks (ASK1, ASK2, and ASK3, encoded by MAP3K5, MAP3K6, and MAP3K15, respectively) is related by sequence homology and its members interact to regulate the activity of one another (16) (17) (18) . ASK1 is the most studied family member and is an upstream kinase of the JNK and p38 pathways (19) . Diverse stimuli such as TLR signaling, ROS, and ER stress can lead to ASK1 activation. Although ASK1 has been shown to regulate cell death by apoptosis (20) and ferroptosis (21) 
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-/-mice remained disease free at the experimental end point of 20 weeks with no evident signs of footpad swelling ( Figure 1A ). On the other hand, Ptpn6 
-/-mice failed to provide any significant protection from the disease ( Figure 1A ), suggesting that deletion of ASK1 alone is sufficient to provide significant protection in Ptpn6 spin mice. However, it should be noted that the progression of disease was delayed in Ptpn6 spin
-/-mice compared with Ptpn6 spin mice, suggesting a partial protective role for ASK2. Histological analysis confirmed that these mice tory disease. ASK1/2 signaling plays a pivotal role in regulating Ptpn6 spin -mediated disease through the control of NF-κB, ERK, and p38 downstream of the IL-1R and TLR pathways, thereby controlling production of proinflammatory cytokines. Taken together, these data show that in addition to its well-known role in apoptosis, the ASK1/2 signaling complex plays a major role in regulating Ptpn6 spin -mediated inflammation and disease.
Results and Discussion

Deletion of ASK signaling ameliorates cutaneous inflammatory disease in Ptpn6
spin mice. The role of IL-1 receptor-and MyD88-driven signaling has been well established in provoking inflammation and inflammatory skin disease in Ptpn6 spin mice (3, 5) . Several studies have demonstrated TAK1 as an essential central regulator of NF-κB, ERK, and p38 downstream of TLR activation (11, 12) . We hypothesized that other MAPKs (ASK1 and ASK2) can also play a crucial role in mediating the inflammatory skin disease in Ptpn6 spin mice. To identify the new players involved in this cutane- 
Ask2
-/-mice (original magnification, ×20). (E) Quantification of the percentage of total area with infiltrating Ly-6G + cells shown in D. Disease curves in A were analyzed by Mantel-Cox log-rank test. (E) Two-way ANOVA was used to determine the significance between the 2 groups analyzed. NS, not significant. ****P < 0.0001. spin mice and produce increased amounts of proinflammatory cytokines such as granulocyte CSF (G-CSF), CXCL1 chemokine KC (CXCL1/KC), and IL-6 (5, 9). We measured the levels of these hallmark cytokines involved in instigating the Ptpn6 spin -associated inflammatory disease progression and neutrophilia. Whereas the serum concentrations of G-CSF, IL-6, CXCL1/KC, MCP-1, IL-1α, and TNF in Ptpn6 spin mice were highly increased, the levels of these cytokines and chemokines were significantly reduced in the sera from Ptpn6 
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-/-mutant mice ( Figure 3A and Supplemental Figure 1A ; supplemental material available online with this article; https://doi.org/10.1172/ JCI98446DS1), indicating an increase in the number of circulating neutrophils in the peripheral blood. The obvious visible defect is in the footpads of the Ptpn6 spin mice, so we first analyzed mRNA showed much less inflammation and fewer lesions compared with Ptpn6 spin mice ( Figure 1 , B and C). Since the inflammation is characterized by heavy infiltration of neutrophils, we further analyzed the footpad sections by neutrophil-specific immunostaining. The staining showed severe neutrophilia in Ptpn6 spin mice, which was completely rescued in the Ptpn6 
-/-mice to confirm the presence of any such abnormalities. Consistent with previous reports (3, 5) , Ptpn6 spin mice displayed splenomegaly in addition to lymphomegaly in the popliteal lymph nodes that drain the inflamed feet ( Figure 2, A and B) . The enlarged spleen and popliteal lymph nodes observed in Ptpn6 spin mice were completely reversed in Ptpn6
-/-mice. In concurrence with the rescue of spleen and popliteal lymph node sizes, the cell numbers in the spleen and popliteal lymph nodes of Ptpn6 
-/-mice were significantly lower than the cell numbers in Ptpn6 spin mice (Figure 2, C and D) . Flow cytometric analysis further revealed 
-/-mice. Each point represents an individual mouse, and the line represents mean ± SEM (C, D, and F). Two-way ANOVA was used to determine significance between the 2 groups analyzed. NS, not significant. **P < 0.01, ***P < 0.001, ****P < 0.0001. 
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-/-prediseased mice. The microabrasion procedure triggered a rapid (5 hours after wound induction) and potent production of inflammatory cytokines and chemokines in WT mice.
expression of Il1a and Tnf in the footpads and the draining lymph nodes of these mice. The quantitative PCR data revealed that genes encoding IL-1α and TNF were highly induced in the Ptpn6 spin mice. However, this aberrant induction of Il1a and Tnf was restored in the Ptpn6
-/-mutant mice (Supplemental Figure 1 , B and C), indicating that IL-1α-driven signaling promotes autoinflammatory disease in Ptpn6 spin mice. We next investigated the cytokine and chemokine concentrations in the footpads of these mice. Similarly, the levels of G-CSF, IL-6, CXCL1/KC, and MCP-1 were significantly reduced in the footpads of Ptpn6
-/-mutant mice when compared with levels in Ptpn6 spin mice ( Figure 3B ). At the site of 
-/-mice were homogenized and the concentrations of cytokines (G-CSF, IL-6) and chemokines (KC/CXCL-1, MCP-1) were measured by ELISA in the quantified lysates. All data are mean ± SEM. Each point represents an individual mouse, and the line represents mean ± SEM. (C) Neutrophils from bone marrow were stimulated with recombinant mouse IL-1α (10 ng/ml) for the indicated time period. Whole-cell lysates were prepared and expression of p-IκBα, IκBα, p-ERK1/2, ERK1/2, p-p38, and p38 was determined by Western blotting. (D) Footpad lysates were prepared and expression of p-IκBα, IκBα, p-ERK1/2, ERK1/2, p-p38, and p38 was determined by Western blotting. β-Actin was used as an internal control. Results are representative of 3 independent experiments. (A and B) Two-way ANOVA was used to determine the significance between the 2 groups analyzed. NS, not significant. *P < 0.05, ***P < 0.001, ****P < 0.0001. ) mice. We used 6-to 10-week-old male and female mice (littermates) in this study unless stated otherwise. All mice were kept in specific pathogen-free conditions within the Animal Resource Center at St. Jude Children's Research Hospital.
Neutrophil isolation and in vitro stimulation. Bone marrow cells were isolated from the femurs of mice and neutrophils (CD11b
were purified by FACS as described elsewhere (5) . Neutrophils (1 × 10 6 cells/ml) were stimulated with 10 ng/ml recombinant murine IL-1α (Gold Biotechnology) or 100 U/ml recombinant IFN-β (PBL Biosciences) for indicated time periods. Cell lysates were collected in RIPA lysis buffer and immunoblotting was performed.
Histopathology. Formalin-preserved feet were processed and embedded in paraffin according to standard procedures. Sections (5 μm) were stained with hematoxylin and eosin (H&E). For immunohistochemistry, formalin-fixed, paraffin-embedded tissues were cut into 4-μm sections and slides were stained with anti-Ly-6G to highlight neutrophils in the footpads, and the images were acquired using light microscopy.
Immunoblot analysis. Footpad protein lysates were collected in RIPA lysis buffer supplemented with complete protease inhibitor cocktail (Roche) and PhosSTOP (Roche) using a tissue homogenizer. Samples were quantified using a Pierce BCA Protein Assay Kit per the manufacturer's instructions, and 40 μg protein was resolved by SDS-PAGE and transferred to PVDF membranes. Membranes were blocked in 5% nonfat milk and incubated overnight at 4°C with primary antibodies. The membranes were then probed with HRPtagged secondary antibodies at room temperature for 1 hour. Immunoreactive proteins were visualized using the Luminata Western HRP chemiluminescence substrate. Antibodies against the following proteins were obtained from Cell Signaling Technology: phospho-ERK1/2 (catalog 9101), ERK1 (catalog 9102), phospho-p38 (catalog 9211), p38 (catalog 9212), phospho-IκBα (catalog 2859), IκBα (catalog 9242), phospho-STAT1 (catalog 9167). Actin was obtained from Proteintech (catalog 66009-1-IG).
In vivo cytokine levels. Blood was collected by submandibular venipuncture and allowed to clot for 60 minutes at room temperature. Serum was collected after centrifugation and cytokines were measured by ELISA. Footpad protein lysates were processed as described above and cytokines were measured by ELISA.
ELISA. Cytokine ELISAs were performed according to the manufacturer's instructions (Milliplex).
Flow cytometry. CD11b (M1/70; Invitrogen) and Gr-1 (RB6-8C5; Biolegend) antibodies were used for flow cytometry. Flow cytometry data were acquired on LSR Fortessa (BD Biosciences) and analyzed using Flowjo software (Tree Star).
RNA interference. For RNAi, HEK293T cells (CRL-3216, ATCC) were transfected with the following siRNAs using Lipofectamine RNAi MAX (Invitrogen) according to the manufacturer's instructions: validated human ASK1 (siRNA 1, Stealth Select RNAi MAP3K5VHS40812) and validated human ASK2 (siRNA 2, Stealth Select RNAi MAP3K6VHS40537).
Statistics. All results are presented as mean ± SEM. Disease curves were analyzed by performing Mantel-Cox log-rank testing, and significant differences between 2 groups were determined using the MannNotably, the enhanced secretion of neutrophilic factors was significantly lowered in Ptpn6
-/-mice (Supplemental Figure 2, A-C 
-/-mice ( Figure 3C) . These results further demonstrate that IL-1α acts as the apical cytokine that signals via ASK1/2 and instigates the inflammatory cascade in Ptpn6 spin mice. To confirm the specificity of this IL-1α-mediated signaling, we further analyzed the involvement of interferon signaling. 
-/-KO neutrophils (Supplemental Figure 3 ). These data are in line with a recent study showing that knockout of IFNAR did not provide protection in Ptpn6 spin mice (9) . Taken together, these data suggest that inflammatory disease in Ptpn6 spin mice is independent of interferon signaling. Since ASK1 has been shown to be involved in regulating activation of JNK and p38 downstream of TLRs (19), we hypothesized that targeted MAPK and NF-κB signaling drives Ptpn6 spin -associated inflammation. We found that in vivo ASK1 and ASK2 deletion markedly reduced local activation of MAPK and NF-κB signaling in the footpads ( Figure 3D ). Taken together, these results are consistent with the hypothesis that IL-1α acts as an apical cytokine that promotes ASK1/2-mediated proinflammatory cytokine and chemokine responses, which ultimately recruit myeloid cells to drive autoinflammatory skin disease in Ptpn6 spin mice. To address the clinical significance of IL-1α and ASK signaling in humans, we performed the knockdown of ASK1 and ASK2 in HEK293T cells (Supplemental Figure 4 , A-C). After confirming the successful knockdown, we stimulated the cells with IL-1α and checked for MAPK signaling. Although IL-1α stimulation did induce MAPK signaling in the control cells, the levels of induction were reduced in the cells with single knockdown of ASK1 and double knockdown of ASK1 and ASK2 (Supplemental Figure 4, D-F) . Interestingly, single knockdown of ASK2 did not show any difference in the activation of MAPK signaling. Consistent with the mice data presented here, double knockdown of ASK1 and ASK2 showed impaired MAPK signaling in response to IL-1α compared with the control cells.
Our results highlight a critical role for ASK-mediated signaling in myeloid cells in driving an inflammatory circuit that triggers excessive inflammatory responses and persistent tissue damage in a mouse model of neutrophilic dermatosis. We have demonstrated that ASK signaling plays an important role in instigating inflammatory disease in Ptpn6 spin mice, as its absence resulted in a substantial resolution of inflammation. The lack of ASK1 and ASK2 in Ptpn6 spin neutrophils led to a marked downregulation of ERK and NF-κB signaling cascades, resulting in a dramatic decrease in inflammatory cytokine production. In summary, our study defines a role for ASK1 and ASK2 in promoting inflammation and disease. Consequently, therapeutic inhibition of ASK1 and ASK2 activity may provide novel approaches to break the self-reinforcing inflammatory circuits that drive chronic autoinflammatory and autoimmune diseases.
